@inproceedings{inproceedings, title  = {{Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence: Preplanned interim results for the AVAST-M trial.}},

 url = {{}},

 year = {{2013}},

 month = {{6}},

 author = {{Corrie P and Marshall A and Goonewardena M and Dunn JA and Middleton MR and Nathan PD and Gore ME and Davidson N and Nicholson S and Kelly CG and Marples M et al}},

 volume = {{31}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 issue = {{18}},

 note = {{Accessed on 2025/01/03}}}